US Broker Ratings

Clover Health Investments, Corp (CLOV) Stock Analysis: Exploring a 54.7% Potential Upside

Clover Health Investments, Corp (NASDAQ: CLOV), a key player in the healthcare sector, offers a compelling opportunity for investors looking to tap into the Medicare Advantage..

PTC Therapeutics, Inc. (PTCT) Investor Outlook: Exploring a 19% Potential Upside

In the ever-evolving landscape of biotechnology, PTC Therapeutics, Inc. (NASDAQ: PTCT) stands out as a key player with a focus on rare disorders. Headquartered in Warren,..

Addus HomeCare Corporation (ADUS) Stock Analysis: 35.96% Upside Potential Sparks Investor Interest

Addus HomeCare Corporation (NASDAQ: ADUS) stands out as a compelling opportunity in the healthcare sector, particularly within the medical care facilities industry. With a current market..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: With a Potential Upside of 243.92%, Is This Healthcare Stock a Hidden Gem?

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a biotechnology company renowned for its innovation in developing therapeutics for rare diseases, presents a compelling opportunity for investors seeking high-growth..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Evaluating a 24.68% Potential Upside for Investors

U.S. Physical Therapy, Inc. (NYSE: USPH) presents a compelling investment opportunity, especially for those looking to capitalize on its robust position in the healthcare sector. With..

Catalyst Pharmaceuticals (CPRX) Investor Outlook: A Promising 41.4% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is capturing the attention of individual investors with its compelling investment proposition. This biopharmaceutical company, headquartered in Coral Gables, Florida, focuses..

BioLife Solutions (BLFS): Investor Outlook on a Healthcare Innovator With a 43% Potential Upside

Investors with an eye on the healthcare sector may find BioLife Solutions, Inc. (NASDAQ: BLFS) an intriguing opportunity. As a key player in the Medical Instruments..

Select Medical Holdings Corp (SEM): Analyst Consensus Indicates 17.65% Potential Upside

Select Medical Holdings Corporation (NYSE: SEM), a prominent player in the healthcare sector, is positioned for intriguing growth potential. With a market capitalization of $1.94 billion,..

Bausch Health Companies Inc. (BHC) Stock Analysis: Robust Free Cash Flow and Potential 24% Upside

Bausch Health Companies Inc. (NYSE: BHC) offers investors a unique proposition within the healthcare sector, particularly in the drug manufacturing industry. With its diversified portfolio spanning..

Establishment Labs Holdings Inc (ESTA): Investor Outlook on a Healthcare Innovator with 19.77% Upside Potential

For investors seeking exposure to the burgeoning medical devices sector, Establishment Labs Holdings Inc (NASDAQ: ESTA) presents an intriguing opportunity. Headquartered in Alajuela, Costa Rica, this..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 41% Upside Potential Amidst Healthcare Innovations

Investors with an eye on the healthcare sector may find Pacira BioSciences, Inc. (NASDAQ: PCRX) an intriguing opportunity. This specialty pharmaceutical company, headquartered in Brisbane, California,..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A Promising 18.12% Upside Potential for Investors

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is capturing the attention of investors with its robust potential for growth in the biopharmaceutical sector, particularly in dermatological treatments. With..

Astrana Health Inc. (ASTH) Stock Analysis: A Compelling 93% Upside Potential in Healthcare

Astrana Health Inc. (ASTH), a prominent player in the healthcare sector, is capturing the attention of investors with its significant upside potential. As a medical care..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring a 115% Potential Upside in the Biotech Arena

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a prominent player in the biotechnology sector, is capturing investor attention with its promising pipeline and substantial potential upside. Headquartered in..

Mesoblast Limited (MESO) Stock Analysis: Exploring a Promising 108.58% Upside Potential

For investors with an eye on the biotechnology sector, Mesoblast Limited (NASDAQ: MESO) presents a compelling opportunity. With its focus on regenerative medicine, this Australian company..

Innoviva, Inc. (INVA) Stock Analysis: Exploring a 50% Potential Upside for Investors

Innoviva, Inc. (NASDAQ: INVA), firmly positioned in the biotechnology sector, presents an intriguing opportunity for investors seeking a blend of growth potential and strategic pharmaceutical innovations...

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 24% Potential Upside in the Medical Devices Sector

UFP Technologies, Inc. (NASDAQ: UFPT), a prominent player in the healthcare sector, has garnered attention with its specialized focus on medical devices and innovative solutions. Headquartered..

Immunocore Holdings plc (IMCR) Stock Analysis: Exploring a 99.94% Potential Upside in Innovative Biotech Ventures

Immunocore Holdings plc (NASDAQ: IMCR) stands at the forefront of biomedical innovation, specializing in developing cutting-edge immunotherapies for a range of serious health conditions, including cancer..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring a Potential 379% Upside in Biotech Innovations

Janux Therapeutics, Inc. (NASDAQ: JANX), a promising player in the biotechnology sector, is capturing investor interest with its innovative approach to cancer treatment. Known for its..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Unveiling a 37.54% Potential Upside

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is turning heads in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. With a market cap..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds